Levoketoconazole

Contraindicated

Levoketoconazole Clindamycin ANTIROBE Explained Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Amitriptyline Elavil Explained An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Sertraline Explained An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Levoketoconazole Buprenorphine Belbuca Explained An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Levoketoconazole Relugolix Orgovyx Explained An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Colchicine Colcrys Explained Increased exposure of CYP3A4/P-gp substrate Details Levoketoconazole Simvastatin Flolipid Explained Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Abemaciclib Verzenio Explained Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Acalabrutinib Calquence Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Amisulpride Injection Barhemsys An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Arsenic Trioxide Trisenox An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Aripiprazole Injection Abilify An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Levoketoconazole Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Avapritinib Ayvakit Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Azithromycin AzaSite An increased risk of QT interval prolongation, an increased risk of serious hepatotoxicity and drug-induced liver injury Details Levoketoconazole Alfuzosin UroXatral An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Levoketoconazole Anagrelide Agrylin An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Avanafil Stendra Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Axitinib Inlyta Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Bedaquiline Sirturo An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Levoketoconazole Brigatinib Alunbrig Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Budesonide Entocort Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Budesonide Nasal Spray Rhinocort Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Budesonide Oral Inhalation Pulmicort Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Chloroquine Aralen® An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Clindamycin Injection ANTIROBE Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Clindamycin Topical C/T/S® Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Clindamycin Vaginal Cleocin Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Cyclosporine Injection Atopica Increased cycloSPORINE exposure, an increased risk of hepatotoxicity and a drug-induced liver injury Details Levoketoconazole Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure, an increased risk of hepatotoxicity and a drug-induced liver injury Details Levoketoconazole Dabigatran Pradaxa® Increased CYP3A4/P-gp substrate exposure Details Levoketoconazole Dabigatran Etexilate Increased CYP3A4/P-gp substrate exposure Details Levoketoconazole Dasatinib Phyrago An increased risk of QT interval prolongation, an increased CYP3A4 substrate exposure and an increased risk of CYP3A substrate-rel... Details Levoketoconazole Degarelix Injection Firmagon An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Deutetrabenazine Austedo An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Levoketoconazole Digoxin Cardoxin® Increased CYP3A4/P-gp substrate exposure Details Levoketoconazole Dihydroergotamine Injection DHE-45® Injection Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Dihydroergotamine Nasal Spray Migranal Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Levoketoconazole Disopyramide Norpace An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details